prescription for compounded semaglutide TrimRX Compounded Semaglutide- Injectable and Sublingual

Beginning in July 2026, CMS will launch a temporary Medicare GLP-1 Bridge program offering eligible Part D beneficiaries access to certain GLP-1 weight loss medications for obesity at an estimated $50 monthly copay

Paradigm Peptides pricing structure Base pricing: Retatrutide pricing at Paradigm Peptides positions within the mid-to-premium range compared to market alternatives

These drugs are more effective than prior available medications in that they directly target hormones that help the patient feel less hungry and more full for a longer period, he explained

The business impact has been limited for most of those initiatives

In the case of these GLP-1 products, enterprising compounders saw an incredible opportunity to build the cash-paying weight-loss market for these products